Bausch + Lomb (Rochester, New York) has concluded
its acquisition of the assets and intellectual property of
Miochol-E from affiliates of Novartis AG (Basel,
Switzerland) in the United States, Canada, Australia, and
Korea, along with various other mark…
Changes induced in keratoconic eyes regressed 3 to 6
months after intracorneal ring segment (ICRS) explantation
depending on the cause of explantation, according
to data presented by Jorge L. Alió, MD, PhD, of Spain, at
the ESCRS.1
Thirty consecutive…
Schwind eye-tech-solutions (Kleinostheim, Germany)
introduced the SmartTech laser system for refractive and
therapeutic corneal surgery at the ESCRS meeting.
The SmartTech is based on nanosecond laser technology
and uses the principle of plasma creati…
The President of the American Society of Cataract and
Refractive Surgery (ASCRS) has responded to criticism of
LASIK from a former US Food and Drug Administration
(FDA) staffer, who said in a letter that a proposed clinical
trial is unethical and will …
Ziemer Group (Port, Switzerland) unveiled a new generation
of its Galilei Dual Scheimpflug Camera System at
the ESCRS meeting. System response, performance, and
computing power have been improved by 30% to 40%
on the updated system, according to a comp…
A customized, near-add approach with the Light
Adjustable Lens (LAL; Calhoun Vision, Inc., Pasadena,
California) is a successful treatment option for presbyopia,
according to a surgeon presenting at the ESCRS
meeting in Paris.1
With more than 350 eyes…